The business of biologics: Aligning IP search and monitoring strategies with market trends
Biologics development is complex and costly, with biosimilars threatening market share and patent expirations looming. This white paper equips pharma executives with IP strategies to monitor patent landscapes, identify competitive risks early, and make data-driven R&D decisions in emerging areas.
.avif)
.avif)
.avif)
.avif)
.avif)
.avif)
